CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

NORGES BANK's Holding History (CIK: 0001374170)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023

Shares 149,100 Value ($000) $2,687 Avg Close $19.94 Range $15.50 - $24.58

Q1 2023

Shares 149,100 Value ($000) $2,395 Avg Close $18.51 Range $15.23 - $21.65

Q1 2022

Shares 25,600 Value ($000) $562 Avg Close $20.24 Range $16.53 - $28.95

Q4 2021

Shares 47,200 Value ($000) $1,341 Avg Close $24.65 Range $18.97 - $28.82

Q3 2021

Shares 21,600 Value ($000) $455 Avg Close $20.92 Range $16.68 - $25.50

Q2 2021

Shares 72,800 Value ($000) $1,372 Avg Close $17.57 Range $15.15 - $21.64

Q1 2021

Shares 33,600 Value ($000) $513 Avg Close $15.50 Range $13.29 - $18.09

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2023	149,100	$2,687	$19.94	$15.50 - $24.58
Q1 2023	149,100	$2,395	$18.51	$15.23 - $21.65
Q1 2022	25,600	$562	$20.24	$16.53 - $28.95
Q4 2021	47,200	$1,341	$24.65	$18.97 - $28.82
Q3 2021	21,600	$455	$20.92	$16.68 - $25.50
Q2 2021	72,800	$1,372	$17.57	$15.15 - $21.64
Q1 2021	33,600	$513	$15.50	$13.29 - $18.09